"10.1371_journal.pone.0098740","plos one","2014-06-04T00:00:00Z","Zou Xiaobai; Chen Xi; Hongping Tian; Ann B Williams; Honghong Wang; Jianmei He; Jun Zhen; Jennifer Chiarella; Lisebeth A Blake; Gregory Turenchalk; Michael J Kozal","Hunan Provincial Center for Disease Control and Prevention, Changsha, Hunan Province, China; Yale-China Association, New Haven, Connecticut, United States of America; UCLA School of Nursing, Los Angeles, California, United States of America; Central South University, Hunan Province, China; Yale School of Medicine, New Haven, Connecticut, United States of America; 454 Life Science, Branford, Connecticut, United States of America","Conceived and designed the experiments: ZX CX HT AW HW JH JZ JC MK. Performed the experiments: ZX CX. Analyzed the data: ZX CX HT AW HW JC LAB GT MK. Contributed reagents/materials/analysis tools: ZX CX LAB GT JC MK. Wrote the paper: ZX CX HT AW HW JC MK.","Yale University receives grant support from Merck, Pfizer, ViiV, Vertex, Gilead, Abbott, Glaxo Smith Kline, Hologic Inc., and Bristol-Myers Squibb for studies that Dr. Kozal serves as the principal investigator. Dr. Kozal is a federal employee and does not receive grant support directly â€ the grant is held by Yale University. Dr. Kozal receives royalties from a patent owned by Stanford University for some HIV genotyping tests. The COI reported by Dr Kozal does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. Lisabeth Blake and Gregory Turenchalk are employees of Roche-454 Life Sciences and their participation does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2014","06","Zou Xiaobai","ZX",11,TRUE,9,2,9,7,TRUE,TRUE,FALSE,0,NA,FALSE
